In Vivo Recognition of Ovalbumin Expressed by Transgenic Leishmania Is Determined by Its Subcellular Localization
- 15 April 2006
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 176 (8) , 4826-4833
Abstract
The importance of the site of Ag localization within microbial pathogens for the effective generation of CD8+ T cells has been studied extensively, generally supporting the view that Ag secretion within infected target cells is required for optimal MHC class I-restricted Ag presentation. In contrast, relatively little is known about the importance of pathogen Ag localization for the activation of MHC class II-restricted CD4+ T cells, despite their clear importance for host protection. We have used the N-terminal targeting sequence of Leishmania major hydrophilic acylated surface protein B to generate stable transgenic lines expressing physiologically relevant levels of full-length OVA on the surface of metacyclic promastigotes and amastigotes. In addition, we have mutated the hydrophilic acylated surface protein B N-terminal acylation sequence to generate control transgenic lines in which OVA expression is restricted to the parasite cytosol. In vitro, splenic dendritic cells are able to present membrane-localized, but not cytosolic, OVA to OVA-specific DO.11 T cells. Strikingly and unexpectedly, surface localization of OVA is also a strict requirement for recognition by OVA-specific T cells (DO.11 and OT-II) and for the development of OVA-specific Ab responses in vivo. However, recognition of cytosolic OVA could be observed with increasing doses of infection. These data suggest that, even under in vivo conditions, where varied pathways of Ag processing are likely to operate, the site of Leishmania Ag localization is an important determinant of immunogenicity and hence an important factor when considering the likely candidacy of vaccine Ags for inducing CD4+ T cell-dependent immunity.Keywords
This publication has 46 references indexed in Scilit:
- Antigen Requirements for Efficient Priming of CD8+T Cells byLeishmania major-Infected Dendritic CellsInfection and Immunity, 2005
- Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigensImmunological Reviews, 2004
- MHC Class II Expression Restricted to CD8α+ and CD11b+ Dendritic Cells Is Sufficient for Control of Leishmania major Journal of Experimental Medicine, 2004
- Two waves of antigen‐containing dendritic cells in vivo in experimental Leishmania major infectionEuropean Journal of Immunology, 2004
- Myristoyl-CoA:Protein N-Myristoyltransferase, an Essential Enzyme and Potential Drug Target in Kinetoplastid ParasitesJournal of Biological Chemistry, 2003
- Tracking Salmonella-Specific CD4 T Cells In Vivo Reveals a Local Mucosal Response to a Disseminated InfectionImmunity, 2002
- Evolutionarily Conserved Proteins as Prominent Immunogens during Leishmania InfectionsParasitology Today, 2000
- Antigen presentation by Leishmania mexicana‐infected macrophages: Activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasitesEuropean Journal of Immunology, 1995
- Induction by Antigen of Intrathymic Apoptosis of CD4 + CD8 + TCR lo Thymocytes in VivoScience, 1990
- A limiting dilution assay for quantifying Leishmania major in tissues of infected miceParasite Immunology, 1985